Quantitative Assays for Catalytic Photo-Oxygenation of Alzheimer Disease-Related Tau Proteins.

Catalytic photo-oxygenation of tau amyloid is a potential therapeutic approach to tauopathies, including Alzheimer disease (AD). However, tau is a complex target containing great molecular size and heterogeneous isoforms/proteoforms. Although catalytic photo-oxygenation has been confirmed when using catalyst 1 and recombinant tau pretreated with heparin, its effects on tau from human patients have not yet been clarified. In this study, focusing on the histidine residues being oxygenated, we have constructed two assay systems capable of quantitatively evaluating the catalytic activity when used on human patient tau: (1) fluorescence labeling at oxygenated histidine sites and (2) LC-MS/MS analysis of histidine-containing fragments. Using these assays, we identified 2 as a promising catalyst for oxygenation of human tau. In addition, our results suggest that aggregated tau induced by heparin is different from actual AD patient tau in developing effective photo-oxygenation catalysts.

[1]  M. Ishikawa,et al.  Switching of Photocatalytic Tyrosine/Histidine Labeling and Application to Photocatalytic Proximity Labeling , 2022, International journal of molecular sciences.

[2]  Yukui Zhang,et al.  A photo-oxidation driven proximity labeling strategy enables profiling of mitochondrial proteome dynamics in living cells , 2022, Chemical science.

[3]  Y. Hori,et al.  Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins , 2022, Frontiers in Aging Neuroscience.

[4]  H. Taguchi,et al.  BODIPY Catalyzes Proximity‐Dependent Histidine Labelling , 2022, ChemCatChem.

[5]  David T. Jones,et al.  Alzheimer disease , 2021, Nature Reviews Disease Primers.

[6]  H. Taguchi,et al.  Proximity Histidine Labeling by Umpolung Strategy Using Singlet Oxygen. , 2021, Journal of the American Chemical Society.

[7]  Y. Hori,et al.  Photo-oxygenation by a biocompatible catalyst reduces amyloid-β levels in Alzheimer's disease mice. , 2021, Brain : a journal of neurology.

[8]  Y. Hori,et al.  Catalytic photooxygenation degrades brain Aβ in vivo , 2021, Science Advances.

[9]  J. O’Hara,et al.  Photoinduced cross-linking of formulation buffer amino acids to monoclonal antibodies. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  A. Kao,et al.  Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation , 2021, Frontiers in Neurology.

[11]  Christoph N Schlaffner,et al.  Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease , 2020, Cell.

[12]  John A. Robinson,et al.  Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networks , 2020, Nature Communications.

[13]  N. Gorantla,et al.  Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer’s Disease , 2019, ACS omega.

[14]  L. Grassi,et al.  Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions , 2019, Amino Acids.

[15]  Y. Hori,et al.  Photo-oxygenation inhibits tau amyloid formation. , 2019, Chemical communications.

[16]  A. Levey,et al.  Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard. , 2019, Journal of proteome research.

[17]  A. Gräslund,et al.  Photoactive chlorin e6 is a multifunctional modulator of amyloid-β aggregation and toxicity via specific interactions with its histidine residues† †Electronic supplementary information (ESI) available: General details on the materials and methods, and any associated references and supporting scheme, , 2018, Chemical science.

[18]  Y. Hori,et al.  Near-Infrared Photoactivatable Oxygenation Catalysts of Amyloid Peptide , 2018 .

[19]  Li Zang,et al.  Discovery and Characterization of Histidine Oxidation Initiated Cross-links in an IgG1 Monoclonal Antibody. , 2017, Analytical chemistry.

[20]  Hanno Steen,et al.  FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease. , 2016, Analytical chemistry.

[21]  Meaghan Morris,et al.  Tau post-translational modifications in wildtype and human amyloid precursor protein transgenic mice , 2015, Nature Neuroscience.

[22]  H. Akiyama,et al.  Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau , 2015, Acta Neuropathologica.

[23]  Peter R Ogilby,et al.  Singlet oxygen: there is indeed something new under the sun. , 2010, Chemical Society reviews.

[24]  John Q Trojanowski,et al.  Olfactory epithelium amyloid‐β and paired helical filament‐tau pathology in Alzheimer disease , 2010, Annals of neurology.

[25]  C. Bertozzi,et al.  Cu-free click cycloaddition reactions in chemical biology. , 2010, Chemical Society reviews.

[26]  Morten Meldal,et al.  Cu-catalyzed azide-alkyne cycloaddition. , 2008, Chemical reviews.

[27]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[28]  Jennifer A. Prescher,et al.  A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. , 2004, Journal of the American Chemical Society.

[29]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.

[30]  Richard Hollister,et al.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.

[31]  R. Crowther,et al.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.

[32]  J. Ávila,et al.  Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .

[33]  R. Crowther,et al.  The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease , 1992, FEBS letters.

[34]  G. Drewes,et al.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.

[35]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[36]  M. Kanai,et al.  Chemical Catalyst-Promoted Photooxygenation of Amyloid Proteins , 2021, Organic & Biomolecular Chemistry.

[37]  Songi Han,et al.  Heparin-induced tau filaments are structurally heterogeneous and differ from Alzheimer's disease filaments. , 2018, Chemical communications.